VigiFlow tips and tricks, including the rationale for coding both drug and reaction, handling dosing intervals and durations, using trade names and active ingredients effectively, leveraging the WHODrug search icon, managing multiple dosages within the same drug tab, and applying advanced search strategies such as "All Names" and "Any Names."
New Legal Provisions on Subcontracting, Strengthened Risk-Based Inspection Cycles, and Updated Regulatory Framework for EU Pharmacovigilance Oversight
Terminology updates, Standardised MedDRA Query (SMQ) modifications, the reversal of medication error term classifications, new translations, and LLT currency status changes.
GLP-1 Receptor Agonists and Vision Loss, Iatrogenic Botulism Risk, Sertraline-Associated Nephrolithiasis, and Ceftriaxone Administration Error
When Digital Health Causes Harm: A Global Review of Real Devices, Apps, and Software That Have Injured or Killed Patients
The dual pharmacovigilance challenge in rare pediatric diseases: first, medications that can cause rare diseases or rare adverse events; and second, the adverse effects of the medications used to treat these conditions.
Off-label prescribing is a necessary and essential component of clinical practice, providing patients with access to therapies that may not otherwise be available. However, the pharmacovigilance blind spot surrounding off-label use poses a significant threat to patient safety.
Advancing Medication Safety Through Knowledge and Vigilance
